Metsera Launches to Lead the Next Generation of Medicines for Obesity and Metabolic Diseases

NEW YORK--(BUSINESS WIRE)--Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, announced its launch today. Founded by Population Health Partners and ARCH Venture Partners and led by former executives of The Medicines Company, Metsera is rapidly advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies designed with best-in-class profiles to address multiple targets a